Syngenta Japan K.K. Appoints Andrew Guthrie as President

20-Nov-2006

Syngenta Japan K.K. announced that Andrew Guthrie has been appointed as the Syngenta Japan K.K. President, effective 1 December 2006.

Since January 2005, Guthrie has been the Country Head for Syngenta Crop Protection Ltd. in Thailand. Earlier assignments include Regional Asia Pacific Head for Marketing and Development in Hong Kong and Singapore and Global Marketing roles in the UK and Switzerland after spending ten years in Australia with ICI Crop Care.

Current President, Michael Kester will return to Europe after several international assignments to lead Syngenta's Vegetable business in Europe, Africa and the Middle East.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

Last viewed contents

Ariadne Expands Presence in South-East Asia - Genomax Technologies to Distribute Ariadne Software in the Region

Hidden RNA repair mechanism discovered in humans - Function of a previously uncharacterized human protein elucidated

Hidden RNA repair mechanism discovered in humans - Function of a previously uncharacterized human protein elucidated

Experience leads to the growth of new brain cells - A new study examines how individuality develops

Experience leads to the growth of new brain cells - A new study examines how individuality develops

Enzo rejects Roche settlement offer - Roche responds with lawsuit

Cold Spring Biotech Corp. to Distribute Strand Genomics' avadis in Taiwan

Syngenta files suit to enforce biotechnology patents

MediGene Receives New US Patent for Cancer-Killing Viruses - Patent protects herpes simplex viruses (HSV) genetically modified to activate the immune system against tumor cells

YM Bioscience reports Phase II data for nimotuzumab in metastatic colorectal cancer - Overall Survival And Disease Control Outcomes, Coupled With Low Toxicity, Support The Continued Development Of The EGFR Antibody In Patients With Colorectal Cancer

SYGNIS completes acquisition of TGR Biosciences

Chemist developed a green catalyst for pharmaceutical and industrial chemistry - Catalyst based on a substance that comes from plant waste

Chemist developed a green catalyst for pharmaceutical and industrial chemistry - Catalyst based on a substance that comes from plant waste

Microbix to spin off Urokinase into newly formed Klarogen Biotherapeutics - Klarogen to acquire all remaining Urokinase inventory, sales and marketing infrastructure and NDA from ImaRx upon completion of financing

Celera Genomics Presents Preclinical Data on its Human Histone Deacetylase (HDAC) Inhibitor